Continuous Wireless Monitoring of Vital Signs and Automated Alerts in Participants at Home and During Hospitalization

Launched by UNIVERSITY HOSPITAL BISPEBJERG AND FREDERIKSBERG · May 17, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new system that continuously monitors patients' vital signs, like heart rate and breathing, using wireless technology. The goal is to see how well this system works in hospitals, especially for patients who are at risk for serious health problems after surgery or due to conditions like lung disease, blood disorders, cancer, heart issues, or infections. Researchers want to find out if patients are monitored effectively and if the healthcare staff are satisfied with the system from the beginning to the end of the trial.

To participate in the study, individuals must be adults aged 18 or older who have been identified by medical staff as being at risk for health complications. However, certain patients may not be eligible, such as those who may not cooperate, those with allergies to specific materials used in the monitoring devices, or those with certain heart devices like pacemakers. Participants will be monitored closely, and their vital signs will be tracked in real-time, which could help doctors respond quickly if any issues arise. This study is currently recruiting participants who fit these criteria.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult participants (≥18 years)
• • Patients assessed by the clinical staff as having an acute condition with risk for clinical deterioration and being either at home (with no apparent need for hospitalization), and/or in hospital OR
• • Patients at either at home before, in-hospital and/or after hospitalization for elective major surgery, defined as surgery lasting more than one hour under general- or regional anaesthesia
• Exclusion Criteria:
• • The participant expected not to cooperate with study procedures.
• • Allergy to plaster or silicone.
• • Having pacemaker or Implantable Cardioverter Defibrillator (ICD) device.
• • Inability to give informed consent.